Secondary malignancy after treatment of Hodgkin's disease: an evolving picture.
Coleman
C N
CN
D000208:Acute Disease; D000328:Adult; D000367:Age Factors; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000009:adverse effects; D002280:Basal Cell Carcinoma / Q000473:pathology*; D003131:Combined Modality Therapy / Q000009:adverse effects; D005500:Follow-Up Studies; D006689:Hodgkin Disease / Q000188:drug therapy / Q000473:pathology* / Q000532:radiotherapy; D006801:Humans; D007558:Italy; D007938:Leukemia / Q000139:chemically induced / Q000473:pathology*; D007953:Leukemia, Radiation-Induced / Q000473:pathology; D008223:Lymphoma / Q000473:pathology*; D008875:Middle Aged; D012306:Risk; D012878:Skin Neoplasms / Q000473:pathology*; D013997:Time Factors